News from sanofi us A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:SAN,NYSE:SNY)

Oct 15, 2014, 13:00 ET

Presenta Sanofi campaña para prevenir osteoartritis en rodillas

La osteoartritis (OA) es una de las primeras 10 causas de invalidez total en México, lo que incrementa la carga económica y social del...

Oct 15, 2014, 08:00 ET

New Survey Finds Differences In Attitudes About Diabetes Based On Age

 Sanofi US announced today the findings of a new survey that reveals striking differences in opinion among various age groups about diabetes...

Sep 17, 2014, 08:34 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease

Sanofi (EURONEXT: SAN and NYSE: SNY) and MyoKardia, Inc., a privately-held company leading the development of precision therapies for genetic...

Sep 10, 2014, 11:00 ET

Sanofi Announces $2.5 Million Contribution to Dementia Research

Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and...

Sep 08, 2014, 14:14 ET

FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

 Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration...

Sep 02, 2014, 12:05 ET
Sanofi (PRNewsFoto/Sanofi and Regeneron Pharm...)

Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

 Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed positive results from four...

Aug 13, 2014, 17:00 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published...

Aug 12, 2014, 08:50 ET
Colorectal Cancer: Early Diagnosis is Key (PRNewsFoto/Sanofi US)

Sanofi Launches Authorized Generic Version of Eloxatin® (oxaliplatin injection)

 Sanofi US announced today that it has launched an authorized generic version of Eloxatin® (oxaliplatin injection) through Winthrop US,...

Aug 11, 2014, 07:00 ET

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin

Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive...

Aug 05, 2014, 12:28 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi: Solid Sales and Business EPS Growth at CER

 Sanofi (NYSE: SNY; EURONEXT: SAN)   Q2 2014 Change (reported) Change (CER) Net...

Jul 31, 2014, 08:00 ET
Sanofi logo.  (PRNewsFoto/Sanofi)

Sanofi: Solid Sales and Business EPS Growth at CER

 Sanofi (NYSE: SNY; EURONEXT: SAN)   Q2 2014 Change (reported) Change (CER) Net...

Jul 31, 2014, 02:28 ET

Sanofi H1 2014 Results - Interview with Chris Viehbacher

Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014. Chris Viehbacher, CEO of Sanofi, comments on...

Jul 31, 2014, 02:25 ET

Sanofi - Résultats T2 2014 - Interview du Directeur Général Chris Viehbacher

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le premier semestre 2014. Le Directeur...

Jul 30, 2014, 08:00 ET
http://www.multivu.com/players/English/7268451-sanofi-and-regeneron-results-from-nine-phase-3-trials-of-alirocumab/gallery/image/840e9af2-54e1-416f-9460-100f608efecd.HR.jpg

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of...

Jul 22, 2014, 08:45 ET
Sanofi Pasteur Logo (PRNewsFoto/Sanofi Pasteur)

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone® (Influenza...

Jul 08, 2014, 08:01 ET

FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo®

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the...

Jun 30, 2014, 10:00 ET

Kids at risk of severe allergies attend soccer clinic hosted by the Montreal Impact and Allerject™

MONTREAL, June 30, 2014 /CNW Telbec/ - For more than 75 youngsters with life-threatening allergies, participating in a soccer clinic hosted by...

Jun 14, 2014, 13:02 ET

Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)

Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that, in a pooled analysis, investigational therapy Toujeo® (insulin glargine [rDNA...

Jun 14, 2014, 13:02 ET

Patients Continuing On Sanofi's Lantus® Had Lower Blood Sugar Levels Than Those who Switched to Insulin Detemir

Sanofi US announced today results from a real world outcome study of type 2 diabetes (T2D) patients that show switching from Lantus® (insulin...

Jun 14, 2014, 13:02 ET

Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering than Liraglutide when Both were Added to Insulin Glargine

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia® (lixisenatide) met the primary endpoint in an 8-week head-to-head...